Periscope Capital’s Aimei Health Technology Co Unit AFJKU Stock Holding History

Periscope Capital’s Portfolio AFJKU Stock Details AFJKU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-150,000	Closed	-$1.53M	–	528
2023 Q4	$1.53M	Buy	+150,000	New	+$1.53M	0.26%	122

Other funds holding AFJKU

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Periscope Capital's AFJKU Position: Q1 2024 in Review

Periscope Capital sold out of Aimei Health Technology Co Unit (AFJKU) in Q1 2024, closing a stake of 150,000 shares — an estimated $1.53M sold.

Periscope Capital first reported a position in AFJKU in Q4 2023 and held it in 1 quarter. The position peaked at $1.53M in Q4 2023. 6 funds tracked by Wall St. Rank hold AFJKU as of Q1 2024.

Periscope Capital reported no remaining Aimei Health Technology Co Unit position as of Q1 2024 after selling out during the quarter.
Periscope Capital sold 150,000 Aimei Health Technology Co Unit shares in Q1 2024, an estimated $1.53M.
Periscope Capital first reported a position in Aimei Health Technology Co Unit in Q4 2023 and held it in 1 quarter.
Periscope Capital's Aimei Health Technology Co Unit position peaked at $1.53M in Q4 2023.
6 funds tracked by Wall St. Rank held Aimei Health Technology Co Unit as of Q1 2024.

Based on Periscope Capital's 13F filing for Q1 2024, filed 13 May 2024.